Transgenomic (TBIO) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
Interest income (expense), net: -285K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest income (expense), net: -285K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q3 EPS of ($0.37), $0.07 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $7.4 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
